Trial Profile

A randomized, placebo-controlled, double-blind dose-finding Phase 2 clinical trial evaluating the efficacy of GT-02287

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 24 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 May 2025 According to Gain Therapeutics media release, company will continue to engage with the FDA and anticipates IND submission by year end.
27 Mar 2025 According to Gain Therapeutics media release, company commenced pre-Investigational New Drug (IND) engagement with U.S. Food and Drug Administration (FDA) in preparation for expansion of GT-02287 Phase 2 clinical development to include the United States.
06 Feb 2025 According to Gain Therapeutics media release, the trial is anticipated to commence in 2H 2025.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com